CXMT IPO Debut in Shanghai Puts $85.5 Billion Chipmaker in Spotlight 
Sika Raises 2026 Sales Outlook After Strong First-Half Results Beat Expectations 
Unilever Raises 2026 Sales Outlook After Strong Q2 Volume Growth 
Nvidia Eyes $250B Guarantee for OpenAI’s Massive Ohio AI Data Center Project 
SK Hynix Q2 Profit Hits Record as AI Memory Chip Demand Fuels Growth 
Zabka Shares Drop 10% as Seven & i Abandons Investment Plans 
Seagate Stock Jumps as AI-Fueled Earnings Beat and Strong FY2027 Outlook Impress Investors 
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook 
Nvidia Invests $1 Billion in Naver as South Korea AI Data Center Expansion Gains Momentum 
Tech Stock Positioning Nears Neutral as Investor Rotation Enters Final Phase, Deutsche Bank Says 
Philips Shares Slide 10% Despite Earnings Beat as Weak Orders Raise Growth Concerns 
BHP, Port Hedland Unions Fail to Reach Wage Deal as Negotiations Continue 
TeamViewer Shares Fall Despite Profit Growth as ARR and Customer Base Decline 
X Challenges Australia’s Expanded Social Media Ban Enforcement Powers 
Johnson & Johnson Proposes $5.5 Billion Talc Settlement to Resolve U.S. Ovarian Cancer Lawsuits 
Rio Tinto Stock Jumps as Strong Earnings, Higher Dividend and AI Metal Demand Boost Outlook 
Canada blocked bulk exports of prescription drugs to the US as it would cause or worsen a drug shortage at home.
The said importation from Canada is President Donald Trump's strategy of lowering some drug prices in the US, which he touted in his debate with President-elect Joe Biden.
Many Canadian drug suppliers opposed Trump's plan as it could lead to shortages,
The “Importation Prescription Drugs” rule in the US would allow licensed US pharmacists or wholesalers to import in bulk certain prescription drugs intended for the Canadian market.
According to Canada's Health Minister Patty Hajdu, companies will be required to provide information to assess existing or potential shortages, which could be as quick as within 24 hours if there is a serious or imminent health risk.
Hajdu emphasized the need for vigilance in maintaining the national drug supply noting that Canada is a small market, representing 2 percent of global drug sales, that sources 68 percent of its drugs internationally.
Canadian Prime Minister Justin Trudeau said in September that his priority was protecting the needs of Canadians in terms of pharmaceutical supplies.
